Actively Recruiting
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2026-03-11
120
Participants Needed
1
Research Sites
299 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with bipolar disorders report an acceleration or slowing of time flow, and patients with schizophrenic spectrum disorders a time fragmentation. These disorders would be linked to disorders of the sense of self. Assessing these time-related disorders could help to better predict psychotic conversion in vulnerable subjects. In this protocol, the investigators wish to develop playful methods for the evaluation of alterations in the passage of time, based on the use of virtual reality. The protocol will be tested in stabilized but chronic bipolar or schizophrenic patients, vs. healthy subjects matched on age, sex, and study level. The protocol will include two experimental sessions. It will begin with a waiting room-like session, at the end of which the subject will be asked to retrospectively estimate the time that will have passed. The games that will follow will all be based on the principle of temporal waiting. A first signal will indicate the start of the trial, and a target will be presented at varying times after this first signal. The later the target is presented, the more the subject expects and prepare for the target, and the faster he or she is. This time delay is measured by the subject's response (response time, error rate, eye fixation), but also by electrical signals measured by electroencephalography (EEG). The two experimental sessions will include several temporal manipulations during these tasks, intended to highlight alterations in the time flow in patients compared to controls. In one of the sessions, a starfield will be presented and the speed of the stars in the starfield will be manipulated, as a proxy for the speed of the environment. In one condition, the speed of the object will be average, and in the other the speed will be self-adjusted by the subject. In a control condition, the speed of the object will be zero. In the other experimental session, distractors will be presented during the waiting phase of the target. They will be presented either simultaneously or asynchronously. In one control condition the distractors will be absent. In both sessions it will be examined how the behavioral and EEG cues are affected by the manipulations. A double dissociation is expected, with greater disturbance in patients with bipolar disorder when standard movement is used, whereas patients with schizophrenia should be disturbed mainly when asynchronous distractors are presented.
CONDITIONS
Official Title
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant, male or female, between 18 and 60 years old
- Affiliated with a social health insurance scheme
- Signed informed consent form
- Women of childbearing age must have a negative pregnancy test and use effective contraception during the study
- Patients under guardianship must have consent from their guardian and themselves if able
- Patients with schizophrenia diagnosis as defined by DSM V
- Patients with bipolar disorder diagnosis as defined by DSM V
- Only patients treated with neuroleptics with or without anti-parkinsonian correctors or antidepressants will be included
You will not qualify if you...
- Substance use disorders as defined by DSM-V
- Use of benzodiazepines (within 5 half-lives before inclusion), cannabis (within 2 months before inclusion), or hallucinogenic substances
- Neurological diseases or sequelae
- Attention Deficit Hyperactivity Disorder (ADHD)
- Borderline personality disorder
- Severe sensory impairment including visual acuity below 0.8 (corrected if applicable)
- Persons deprived of liberty or under legal protection
- Pregnant, parturient, or breastfeeding women
- Participation in another clinical study exclusion period
- Healthy volunteers with major neurological or psychiatric illness under psychotropic medication
- Patients taking benzodiazepines
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Services de Psychiatrie I et II - Pôle de Psychiatrie CHRU Strasbourg
Strasbourg, France, 67091
Actively Recruiting
Research Team
G
GIERSCH GIERSCH, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here